SCHEMBL9554273

SCHEMBL9554273

C#CCCc1cn(CC)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 4/20 0.49
AGTR2 P50052 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9554382 0.93 AGTR1 (0.53) AGTR1AGTR2
SCHEMBL9533160 0.92 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9554398 0.92 AGTR1 (0.45) AGTR1AGTR2
SCHEMBL9532713 0.91 AGTR1 (0.61) AGTR1AGTR2
SCHEMBL9554130 0.91 AGTR1 (0.57) AGTR1AGTR2
SCHEMBL9530595 0.91 AGTR1 (0.45) AGTR1AGTR2
SCHEMBL9035255 0.90 AGTR1 (0.54) AGTR1AGTR2
SCHEMBL9529815 0.90 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9553989 0.89 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9035928 0.88 AGTR1 (0.62) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed